Fungal infections should be part of the core outcome set for COVID-19

por Verweij, Paul E, Alanio, Alexandre
Publicado 2021

Managing secondary fungal infections in severe COVID-19: how to move forward?

por Verweij, Paul E, van de Veerdonk, Frank L
Publicado 2022

Discovery and characterization of novel Aspergillus fumigatus mycoviruses

por Zoll, Jan, Verweij, Paul E., Melchers, Willem J. G.
Publicado 2018

Invasive Aspergillus Tracheobronchitis Emerging as a Highly Lethal Complication of Severe Influenza

por van de Veerdonk, Frank L., Wauters, Joost, Verweij, Paul E.
Publicado 2020

Next-Generation Sequencing in the Mycology Lab

por Zoll, Jan, Snelders, Eveline, Verweij, Paul E., Melchers, Willem J. G.
Publicado 2016

Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis – Authors' reply

por Koehler, Philipp, White, P Lewis, Verweij, Paul E, Cornely, Oliver A
Publicado 2021

Azole-Resistance Development; How the Aspergillus fumigatus Lifecycle Defines the Potential for Adaptation

por Zhang, Jianhua, Debets, Alfons J. M., Verweij, Paul E., Snelders, Eveline
Publicado 2021

Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

por Verweij, Paul E., Chowdhary, Anuradha, Melchers, Willem J. G., Meis, Jacques F.
Publicado 2016

Molecular Detection of Azole-Resistant Aspergillus fumigatus in Clinical Samples

por Buil, Jochem B., Zoll, Jan, Verweij, Paul E., Melchers, Willem J. G.
Publicado 2018

Selective Flamingo Medium for the Isolation of Aspergillus fumigatus

por Zhang, Jianhua, Debets, Alfons J. M., Verweij, Paul E., Schoustra, Sijmen E.
Publicado 2021

Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates

por Buil, Jochem B., Hagen, Ferry, Chowdhary, Anuradha, Verweij, Paul E., Meis, Jacques F.
Publicado 2018

Differential Functions of Individual Transcription Factor Binding Sites in the Tandem Repeats Found in Clinically Relevant cyp51A Promoters in Aspergillus fumigatus

por Paul, Sanjoy, Verweij, Paul E., Melchers, Willem J. G., Moye-Rowley, W. Scott
Publicado 2022

High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints

por Jansen, Anouk M. E., ter Heine, Rob, Verweij, Paul E., Brüggemann, Roger J. M.
Publicado 2023

P001 Characteristics and dynamics of azole-resistant Aspergillus fumigatus variants emerging over a 28-year period in the Netherlands

por Song, Yinggai, Buil, Jochem B, Melchers, Willem J G, Zoll, Jan, Verweij, Paul E
Publicado 2022

Genotyping of Aspergillus fumigatus in Formalin-Fixed Paraffin-Embedded Tissues and Serum Samples From Patients With Invasive Aspergillosis

por de Groot, Theun, Hagen, Ferry, Vreuls, Willem, Verweij, Paul E., Chowdhary, Anuradha, Meis, Jacques F.
Publicado 2018

Trends in Azole Resistance in Aspergillus fumigatus, the Netherlands, 1994–2016

por Buil, Jochem B., Snelders, Eveline, Denardi, Laura Bedin, Melchers, Willem J.G., Verweij, Paul E.
Publicado 2019

Reply to Mafaciolli and Pasqualotto

por Verweij, Paul E, Maertens, Johan, Chen, Sharon C-A, Pappas, Peter G, Donnelly, J Peter
Publicado 2020

Absence of candidemia in critically ill patients with COVID-19 receiving selective digestive decontamination

por Buil, Jochem B., Schouten, Jeroen A., Wauters, Joost, van de Hoeven, Hans, Verweij, Paul E.
Publicado 2022

Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis

por van der Linden, Jan W.M., Arendrup, Maiken C., Melchers, Willem J.G., Verweij, Paul E.
Publicado 2016

Burden of serious fungal infections in the Netherlands

por Buil, Jochem B., Meijer, Eelco F. J., Denning, David W., Verweij, Paul E., Meis, Jacques F.
Publicado 2020